Octave Bioscience

Menlo Park, CA · Founded 2014 · Privately Held (backing)

Operator of a biomarker-driven precision medicine company intended to improve monitoring and treatment decisions for neurodegenerative diseases. Octave Bioscience is based in Menlo Park, CA and was founded in 2014. Its last reported valuation was $143 million in Jul 2023. It has raised $129 million across 5 recorded rounds; the latest was a $31.8 million early-stage round in Mar 2025.

Last reported valuation
$143.0M
Oct 2026
Priced at
—
Total raised
$129.2M
Last round
Early Stage VC
Mar 2025

Who backs Octave Bioscience?

18 investors
InvestorType
European Innovation CouncilVenture capital
Kleiner PerkinsOther
S32Venture capital
Deerfield ManagementVenture capital
Casdin CapitalVenture capital
MSD Global Health Innovation FundVenture capital
Echo Health VenturesVenture capital
Sandbox IndustriesVenture capital
Valhalla FoundationOther
Blue Venture Fund—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Octave Bioscience investors

18 investors are on record for Octave Bioscience, including European Innovation Council, Kleiner Perkins, S32 and Deerfield Management. By type, the record holds 7 venture capital firms. The early-stage round in Mar 2025 drew 20 investors.

Free account
More of Octave Bioscience with a free account
  • ·The complete investor list: 18 names
  • ·Watch Octave Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Octave Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View